Nyxoah Raises $110 Million to Accelerate US Launch of Genio Sleep Apnea Device

MT Newswires Live
06/11

Nyxoah (NYXH) secured $110 million in new capital to support the US commercial rollout of its Genio sleep apnea treatment system, the medical technology company said late Wednesday.

The company completed a $95 million equity financing and expects to receive the second $15 million tranche of its European Investment Bank loan by the end of June.

Nyxoah said the funding will help accelerate the commercialization of Genio in the US, where it has built a sales force of 40 representatives following the device's US Food and Drug Administration approval in 2025.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10